Literature DB >> 33246088

Virulence, resistance and clonality of Proteus mirabilis isolated from patients with community-acquired urinary tract infection (CA-UTI) in Brazil.

Wellington Danilo de Oliveira1, Mário Gabriel Lopes Barboza1, Gabriela Faustino1, Willian Teruhiko Yamanaka Inagaki1, Matheus Silva Sanches1, Renata Katsuko Takayama Kobayashi2, Eliana Carolina Vespero3, Sergio Paulo Dejato Rocha4.   

Abstract

Urinary tract infections (UTIs) are among the most common human infections, both in hospitals and in communities. Proteus mirabilis is known to cause community-acquired urinary tract infection (CA-UTI) and is an important causative agent of nosocomial UTIs. The pathogenesis of this species is related to its ability to manifest virulence factors, such as biofilms, adhesion molecules, urease, proteases, siderophores, and toxins. In this study, we investigated the virulence, sensitivity to antimicrobials, and clonal relationship of 183 strains isolated from the urine of CA-UTI patients in Londrina, Paraná State, Brazil. A total of 100% of the strains were positive for hpmA, ptA, zapA, mrpA, pmfA, ireA, and atfA virulence genes. The ucaA gene was positive in 81.4% of the cases. The strains showed high rates of sensitivity to the evaluated antimicrobials, and only one was ESBL-positive. All the tested bacteria showed the capacity to form biofilms: 73.2% had a very strong intensity, while 25.7% had a strong intensity, and 1.1% had a moderate intensity. Regarding clonality, 40 clonal clusters were found among the microorganisms tested. Our results showed that strains of P. mirabilis isolated from CA-UTI patients have several virulence factors. Although the urinary clinical isolates studied showed high sensitivity to antimicrobials, the strains showed a strong capacity to form biofilms, making antibiotic therapy difficult. In addition, it was observed that there were clones of P. mirabilis circulating in the city of Londrina.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Antimicrobial resistance; Bacterial pathogenesis; Biofilm; Clonal relationship; Urinary infection; Virulence genes

Mesh:

Year:  2020        PMID: 33246088      PMCID: PMC7938216          DOI: 10.1016/j.micpath.2020.104642

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  29 in total

1.  Virulence of a Proteus mirabilis ATF isogenic mutant is not impaired in a mouse model of ascending urinary tract infection.

Authors:  P Zunino; L Geymonat; A G Allen; C Legnani-Fajardo; D J Maskell
Journal:  FEMS Immunol Med Microbiol       Date:  2000-10

2.  Potential Probiotics Bacillus subtilis KATMIRA1933 and Bacillus amyloliquefaciens B-1895 Co-Aggregate with Clinical Isolates of Proteus mirabilis and Prevent Biofilm Formation.

Authors:  Ammar Algburi; Sarah A Alazzawi; Ali Ibrahim Ali Al-Ezzy; Richard Weeks; Vladimir Chistyakov; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2020-12       Impact factor: 4.609

3.  Epidemiology of Escherichia coli, Klebsiella species, and Proteus mirabilis strains producing extended-spectrum β-lactamases from clinical samples in the Kinki Region of Japan.

Authors:  Tatsuya Nakamura; Masaru Komatsu; Katsutoshi Yamasaki; Saori Fukuda; Yugo Miyamoto; Takeshi Higuchi; Tamotsu Ono; Hisaaki Nishio; Noriyuki Sueyoshi; Kenji Kida; Kaori Satoh; Hirofumi Toda; Masahiro Toyokawa; Isao Nishi; Masako Sakamoto; Masahiro Akagi; Isako Nakai; Tomomi Kofuku; Tamaki Orita; Yasunao Wada; Takuya Zikimoto; Chihiro Koike; Shohiro Kinoshita; Itaru Hirai; Hakuo Takahashi; Nariaki Matsuura; Yoshimasa Yamamoto
Journal:  Am J Clin Pathol       Date:  2012-04       Impact factor: 2.493

4.  Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Enterobacteriaceae- related urinary tract infections.

Authors:  Ayhanim Tumturk; Senol Tonyali; Ayse Yasemin Tezer Tekce; Levent Isikay; Hakan Cime
Journal:  J Infect Dev Ctries       Date:  2019-01-31       Impact factor: 0.968

5.  Molecular detection of HpmA and HlyA hemolysin of uropathogenic Proteus mirabilis.

Authors:  Silvia Emanoele Cestari; Marilucia Santos Ludovico; Fernando Henrique Martins; Sérgio Paulo Dejato da Rocha; Waldir Pereira Elias; Jacinta Sanchez Pelayo
Journal:  Curr Microbiol       Date:  2013-07-25       Impact factor: 2.188

6.  Frequency and Antibiotic Resistance of Bacteria Implicated in Community Urinary Tract Infections in North Aveiro Between 2011 and 2014.

Authors:  Tânia Costa; Inês Linhares; Ricardo Ferreira; Jasmin Neves; Adelaide Almeida
Journal:  Microb Drug Resist       Date:  2017-09-18       Impact factor: 3.431

7.  Bacterial susceptibility to oral antibiotics in community acquired urinary tract infection.

Authors:  D Prais; R Straussberg; Y Avitzur; M Nussinovitch; L Harel; J Amir
Journal:  Arch Dis Child       Date:  2003-03       Impact factor: 3.791

8.  Characterization of antimicrobial resistant Escherichia coli isolated from processed bison carcasses.

Authors:  Q Li; J S Sherwood; C M Logue
Journal:  J Appl Microbiol       Date:  2007-12       Impact factor: 3.772

9.  qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin.

Authors:  L M Cavaco; H Hasman; S Xia; F M Aarestrup
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

10.  The bacterial amyloid curli is associated with urinary source bloodstream infection.

Authors:  Chia Hung; Jonas Marschall; Carey-Ann D Burnham; Albert S Byun; Jeffrey P Henderson
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

View more
  1 in total

1.  From the Urinary Catheter to the Prevalence of Three Classes of Integrons, β-Lactamase Genes, and Differences in Antimicrobial Susceptibility of Proteus mirabilis and Clonal Relatedness with Rep-PCR.

Authors:  Arezoo Mirzaei; Bahram Nasr Esfahani; Abbasali Raz; Mustafa Ghanadian; Sharareh Moghim
Journal:  Biomed Res Int       Date:  2021-06-10       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.